Banque Pictet & Cie Sa Global Blood Therapeutics, Inc. Transaction History

Banque Pictet & Cie Sa

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$22.3 - $37.39 $90,025 - $150,943	-4,037 Reduced 8.79%	41,898 $1.34 Million
Q1 2022 May 04, 2022	BUY	$25.68 - $35.59 $45,633 - $63,243	1,777 Added 4.02%	45,935 $1.59 Million
Q4 2021 Feb 02, 2022	BUY	$24.9 - $40.26 $1.1 Million - $1.78 Million	44,158 New	44,158 $1.29 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.